Novo took the active ingredient of Ozempic, semaglutide, and rebranded it as Wegovy to be used specifically for weight loss.

Three new studies suggest that Ozempic and related diabetes and weight loss drugs may help protect the brain from strokes.

The Center for Medicare and Medicaid Innovation may introduce a five-year pilot model to expand access to weight loss drugs, ...

Despite this, one in five young adults who meet the criteria for the drugs are uninsured and one-third denied having a routine place for healthcare.

Novo's shares plunged amid rising competition, missed expectations, and governance issues, exposing the risks of neglecting ...

Novo Nordisk , maker of the weight-loss drug Wegovy, has been sued in U.S. court by investors claiming the Danish ...

Pediatricians in Utah can prescribe weight loss drugs for adolescents over 12 years of age, according to the American Academy ...

When it was riding high, Novo Nordisk could have done M&A to reduce its dependence on obesity treatments. It didn’t.

GLP-1 medications like Ozempic, Wegovy, and Mounjaro are changing the weight loss game. But there’s a catch—and most people don’t hear about it until it’s too late. Yes, these medications suppress ...

Unless you’ve been living on another planet over the past few years, you have heard of and probably know several people that ...

INFLUENCER and YouTube star Tana Mongeau has issued a dramatic warning to fans after trying the weight loss jab Mounjaro. The ...

Researchers created a targeted fat loss therapy using light-sensitive nanoparticles that activate fat-burning processes ...